Qi Hu is a bioanalytical scientist with extensive experience in assay development. They began their career as a QC Analyst at Berlex Laboratories (2003 - 2007) before moving to ZymoGenetics as a QC Associate III (2007 - 2010). Following this, Qi worked as a Bioanalytical Scientist at Alder Biopharmaceuticals (2010 - 2020) and most recently held the position of Senior Scientist at Seagen (2022 - 2023). Currently, Qi serves as a Principal Scientist at Pfizer, leading bioanalytical assay development for ADC programs. Qi earned a degree in Biochemistry from the University of Washington (1998 - 2002).
This person is not in the org chart
This person is not in any teams
This person is not in any offices